Categories: News

Certara Announces New Chief Human Resources Officer

Veteran HR leader brings 20+ years of human resources experience to the company’s executive team

PRINCETON, N.J., July 13, 2021 (GLOBE NEWSWIRE) — Certara®, a global leader in biosimulation, today announced that it has appointed Nicolette D. Sherman to the position of Chief Human Resources Officer (CHRO). Sherman joins Certara with extensive experience in the biopharmaceutical industry, leading HR strategy and implementing programs to drive business impact.

“We are pleased to have Nicolette join Certara as we continue to grow our high-performing team and capabilities worldwide,” said William F. Feehery, chief executive officer. “She has a proven track record of achieving organizational results through advancing corporate values and building competencies. We look forward to her contributions to Certara.”

Most recently, Sherman was CHRO at Oyster Point Pharma, where she developed the human resources function of the newly public biotech company, establishing the infrastructure needed to support commercialization. Prior to that, she served in multiple roles at Sanofi for 12 years, including Vice President of North American Human Resources Operations and Vice President of Global Leadership Development. Sherman was responsible for leading a large team of HR professionals, providing support across all areas of the employment cycle for the 5 diverse business units and all functional areas in North America.

“I am honored to join Certara and look forward to contributing to its important work in transforming drug development and bringing new therapies to market,” said Ms. Sherman. “Certara has impressive breadth and depth of scientific and regulatory expertise, and I am excited to play a role in continuing to build upon the world-class team.”

About Certara
Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Ariane Lovell
Finn Partners
ariane.lovell@finnpartners.com

Staff

Recent Posts

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists…

11 minutes ago

BoomRx Debuts Single Portal for Prescription Sourcing and Fulfillment

New Technology Platform Reduces Administrative Burden for Healthcare Providers NationwideTAMPA, Fla., Dec. 12, 2025 /PRNewswire/…

11 minutes ago

CluePoints Scoops Prestigious 2025 Scrip Award

RBQM and AI leader wins the 'Best Contract Research Organization – Specialist Providers' categoryKING OF…

11 minutes ago

Global Attention: POGMENT Biomimetic Collagen “Stable Triple-Helix Breakthrough” –Unconventional and Astonishing

— LivingPhoenix Forum's 12 Conference Presentation Ignite International and Domestic Academia, Hailed by Academicians as…

11 minutes ago

Acclinate Named Bronze Winner for Digital Health Innovation at the 5th Annual Anthem Awards

BIRMINGHAM, Ala., Dec. 12, 2025 /PRNewswire/ -- Acclinate announced today that its community platform, NOWINCLUDED,…

12 minutes ago

Cadrenal’s Quiet Expansion Play Is Starting to Get Loud

PONTE VEDRA, FL / ACCESS Newswire / December 12, 2025 / Cadrenal Therapeutics (NASDAQ:CVKD) entered…

12 minutes ago